Clinical trial
GW873140 In Combination With Combivir In HIV Infected Subjects
NCT00104429 · ViiV Healthcare, Industry · Terminated
Key facts
| NCT number | NCT00104429 |
|---|---|
| Title | GW873140 In Combination With Combivir In HIV Infected Subjects |
| Official title | A PhaseIIb, 96 Week, Randomised, Partially Double-blinded, Multicentre, Parallel Group, Repeat Dose Study to Evaluate the Safety, Tolerability, PK and Antiviral Effect of GW873140 in Combination With COMBIVIR (Lamivudine and Zidovudine) Upon Selected Immunological and Virological Markers of HIV-1… |
| Lead sponsor | ViiV Healthcare, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Infection, Human Immunodeficiency Virus I, HIV Infection |
| Intervention type | Drug |
| Interventions | GW873140, Combivir |
| Enrollment | 125 |
| Start date | Jan 1, 2005 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Mar 1, 2005 |
| Last update posted | May 30, 2017 |
| Countries | Belgium, Canada, France, Germany, Italy, Portugal, Spain, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: